| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |